Kordasiewicz Holly B.
SEC CIK 2102721 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IONS | IONIS PHARMACEUTICALS INC | EVP, Chief Development Off | 22.1K | — | $4.81M | 5 | 2026-01-15 | 2026-07-07 |
Most active insiders at IONS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Monia Brett P | CEO, Dir | — | $30.35M |
| 2 | HOUGEN ELIZABETH L | EVP, CFO, Fin | — | $21.12M |
| 3 | BENNETT C FRANK | EVP, CSO | — | $16.71M |
| 4 | Geary Richard S | EVP, Chief Development Off | — | $13.35M |
| 5 | O'NEIL PATRICK R. | GC, EVP CLO | — | $9.17M |
| 6 | Devers Shannon L. | EVP, Chief Human Resources Ofc | — | $8.66M |
| 7 | Swayze Eric | EVP Research | — | $7.51M |
| 8 | LOSCALZO JOSEPH | Dir | — | $7.09M |
| 9 | KLEIN JOSEPH III | Dir | — | $6.00M |
| 10 | WENDER JOSEPH H | Dir | — | $5.44M |
| 12 | Kordasiewicz Holly B. | EVP, Chief Development Off | — | $4.81M |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-07-09 18:07 | 2026-07-07 | IONS | IONIS PHARMACEUTICALS INC | Kordasiewicz Holly B. | EVP, Chief Development Off | S - Sale | $84.30 | -362 | 22.1K | -2% | -$30.5K |
| DMT | 2026-06-16 17:26 | 2026-06-12 | IONS | IONIS PHARMACEUTICALS INC | Kordasiewicz Holly B. | EVP, Chief Development Off | M - OptEx | $53.97 | +60.8K | 83.3K | +271% | +$3.28M |
| DMT | 2026-06-16 17:26 | 2026-06-12 | IONS | IONIS PHARMACEUTICALS INC | Kordasiewicz Holly B. | EVP, Chief Development Off | S - Sale+OE | $73.41 | -60.8K | 22.5K | -73% | -$4.47M |
| D | 2026-01-20 | 2026-01-15 | IONS | IONIS PHARMACEUTICALS INC | Kordasiewicz Holly B. | EVP, Chief Development Off | M - OptEx | $0.00 | +11.1K | 18.9K | +144% | $0 |
| D | 2026-01-20 | 2026-01-16 | IONS | IONIS PHARMACEUTICALS INC | Kordasiewicz Holly B. | EVP, Chief Development Off | S - Sale+OE | $75.66 | -4,141 | 14.7K | -22% | -$313.3K |
Purchase Sale Sale after option exercise All abbreviations